Does Adjunctive Chemotherapy Reduce Remission Rates Compared to Cortisone Alone in Unifocal or Multifocal Histiocytosis of Bone? (2012)
- Authors:
- USP affiliated authors: ODONE FILHO, VICENTE - FM ; CAMARGO, OLAVO PIRES DE - FM
- Unidade: FM
- DOI: 10.1007/s11999-011-2162-x
- Subjects: DOENÇAS INFECCIOSAS (DIAGNÓSTICO); NEOPLASIAS (QUIMIOTERAPIA); DOENÇAS INFECCIOSAS (CLASSIFICAÇÃO); DOENÇAS ÓSSEAS
- Language: Inglês
- Imprenta:
- Source:
- Título: Clinical Orthopaedics and Related Research
- ISSN: 0009-921X
- Volume/Número/Paginação/Ano: v. 470, n. 3, p. 663-669, 2012
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
BAPTISTA, André Mathias et al. Does Adjunctive Chemotherapy Reduce Remission Rates Compared to Cortisone Alone in Unifocal or Multifocal Histiocytosis of Bone?. Clinical Orthopaedics and Related Research, v. 470, n. 3, p. 663-669, 2012Tradução . . Disponível em: https://doi.org/10.1007/s11999-011-2162-x. Acesso em: 28 fev. 2026. -
APA
Baptista, A. M., Camargo, A. F. F., Camargo, O. P. de, Odone Filho, V., & Cassone, A. E. (2012). Does Adjunctive Chemotherapy Reduce Remission Rates Compared to Cortisone Alone in Unifocal or Multifocal Histiocytosis of Bone? Clinical Orthopaedics and Related Research, 470( 3), 663-669. doi:10.1007/s11999-011-2162-x -
NLM
Baptista AM, Camargo AFF, Camargo OP de, Odone Filho V, Cassone AE. Does Adjunctive Chemotherapy Reduce Remission Rates Compared to Cortisone Alone in Unifocal or Multifocal Histiocytosis of Bone? [Internet]. Clinical Orthopaedics and Related Research. 2012 ; 470( 3): 663-669.[citado 2026 fev. 28 ] Available from: https://doi.org/10.1007/s11999-011-2162-x -
Vancouver
Baptista AM, Camargo AFF, Camargo OP de, Odone Filho V, Cassone AE. Does Adjunctive Chemotherapy Reduce Remission Rates Compared to Cortisone Alone in Unifocal or Multifocal Histiocytosis of Bone? [Internet]. Clinical Orthopaedics and Related Research. 2012 ; 470( 3): 663-669.[citado 2026 fev. 28 ] Available from: https://doi.org/10.1007/s11999-011-2162-x - Results of the Brazilian Osteosarcoma Treatment Group Studies III and IV: Prognostic Factors and Impact on Survival
- Activity of intraarterial carboplatin as a single agent in the treatment of newly diagnosed extremity osteosarcoma
- Gene expression profile analysis between CD10 positive standard risk all with good and poor response to induction theraphy:: identification of potencial target genes
- Aspectos clllínicos, terapêuticos e variáveis de prognostico em crianças maiores de um ano portadoras de neuroblastoma não disseminado
- Prognostic factors and expression of MDM2 in patients with primary extremity liposarcoma
- Fatores prognósticos nas fraturas patológicas por tumores metastáticos
- Platelet-Rich Plasma in Rotator Cuff Repair: A Prospective Randomized Study
- TUG and FTSST in knee oa patients submited to an educacional program (Parqve-Project Arthritis Recovering Quality of Life by Means of Education)
- Early surgical intervention in painful long bone metastasis based on MRI
- Immunohistochemical analysis using prognostic antigens of four deddiferentiated chondrosarcomas
Informações sobre o DOI: 10.1007/s11999-011-2162-x (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
